Skip to main content
. 2021 Feb 2;11:2792. doi: 10.1038/s41598-021-82502-y

Figure 3.

Figure 3

Evolution of the ash fraction, volume fraction and damage for the control case, and different doses of denosumab (0.1, 0.3, 3.0 mg/kg) and Ibandronate (0.25, 0.5, 1.0 and 2.0 mg) when applying constant stress of 1.0 MPa for an initial density of ρ=0.5g/cm3, 7.0 MPa for an initial density of ρ=1.0g/cm3 and 34 and 54 MPa for an initial density of ρ=2.05g/cm3.